Akari Therapeutics Plc - American Depositary Shares — Cash Flow (NASDAQ:AKTX) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Cash from operating activities 16.95 M-18.85 M-21.5 M16.43 M12.55 M 9.65 M Cash from investing activities ————382 K — Cash from financing activities 25.07 M14.29 M25.29 M7.02 M10.99 M 9.56 M Free cash flow 16.95 M-18.85 M-21.5 M16.43 M12.55 M 9.65 M

Nachrichten

Akari Therapeutics verstärkt wissenschaftlichen Beirat mit RNA-Spleiß-Expertin

Akari Therapeutics adds RNA splicing expert to advisory board

Why Vanda Pharmaceuticals Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Antelope Ent Hldgs (NASDAQ:AEHL), Aimei Health Technology (NASDAQ:AFJK)

Akari Therapeutics treibt Onkologie-Programm mit neuartigem ADC-Wirkstoff voran

Akari Therapeutics advances ADC oncology program with novel payload

Akari startet GMP-Produktion für führendes ADC-Programm mit WuXi XDC

Akari begins GMP manufacturing of lead ADC program with WuXi XDC

Akari Therapeutics beschafft 5 Millionen US-Dollar durch marktkonforme Emission

Akari Therapeutics raises $5 million in at-market offering

Vielversprechende Krebsdaten treiben Aktie von Akari Therapeutics an

Akari Therapeutics stock rises on promising pancreatic cancer drug data

Nasdaq-Verwarnung für Akari Therapeutics wegen Unterschreitung des Mindestkurses